Reset filter
Mots-clés
D016430 ×
Afficher plus Mots-clés
Table des matières
  1. 1. Test clinico
    1. 1.1. Determinazione dell`idoneità
    1. 1.2. Storia medica
    1. 1.3. Esame fisico
    1. 1.4. Punteggio di valutazione
    1. 1.5. Diagnostica Apparativa
    1. 1.6. Laboratorio
    1. 1.7. Patologia / Istologia
    1. 1.8. Consenso
    1. 1.9. Terapia
    1. 1.10. Rapporto operativo
    1. 1.11. Evento avverso
    1. 1.12. Azione supplementare
  2. 2. Documentazione di routine
  3. 3. Registro / studio di coorte
  4. 4. Garanzia di qualità
  5. 5. Dati Standard
  6. 6. Risultato segnalato dal paziente
  7. 7. Specialità mediche
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

482 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Surgical Reporting Form - FORM C

- 27/06/15 - 1 Formulaire, 3 Groupes Item, 24 Eléments de données, 1 Langue
Groupes Item: Patient demographics, Surgery assessment, Comments
NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Surgical Reporting Form - FORM C Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA3F6FCF-2BF6-2D9B-E034-0003BA12F5E7

LASER ADMINISTRATION FELLOW EYE (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382

- 28/06/17 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Patient administration, LASER ADMINISTRATION STUDY EYE
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

ChroPac-trial: duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis - start

- 06/02/23 - 7 Formulaires, 11 Groupes Item, 40 Eléments de données, 1 Langue
Groupes Item: Date of Visit, Inclusion Criteria, Exclusion Criteria, Quality of Life, Demography, Clinical Data, Duration of Symptoms, Imaging Techniques, Results preop imaging, Results preop Endoscopy, ERCP
Duodenum-preserving head resection versus pancreatico-duodenectomy for chronic pancreatitis of the head. Study Center of the German Surgical Society (SDGC) Trial protocol of a randomised controlled multicentre trial. Trials. 2010 Apr 29;11:47. doi: 10.1186/1745-6215-11-47. PMID: 20429912; PMCID: PMC2874785. Controlled-trials.com ISRCTN38973832

start

9 Groupes Item 14 Eléments de données

start

6 Groupes Item 15 Eléments de données

start

6 Groupes Item 19 Eléments de données

start

6 Groupes Item 14 Eléments de données

start

6 Groupes Item 14 Eléments de données

start

5 Groupes Item 11 Eléments de données

Eligibility Insufficiency; Cardiac, Complicating Surgery NCT02231463

- 21/04/20 - 1 Formulaire, 2 Groupes Item, 13 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Influence of Two Different PEEP Niveaus and a Trendelenburg Positioning Manoeuvre on Subclavian Vein Diameter; ODM derived from: https://clinicaltrials.gov/show/NCT02231463

Eligibility Cardiothoracic Surgery NCT02029534

- 18/10/19 - 1 Formulaire, 2 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF); ODM derived from: https://clinicaltrials.gov/show/NCT02029534

Eligibility Cardiac Surgery NCT01552187

- 18/10/19 - 1 Formulaire, 2 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial); ODM derived from: https://clinicaltrials.gov/show/NCT01552187

Pre-Study - PRIOR SURGERY SUPPLEMENT - 2398212v1.0 - PRIOR SURGERY SUPPLEMENT

- 20/09/21 - 1 Formulaire, 2 Groupes Item, 8 Eléments de données, 1 Langue
Groupes Item: PRIOR SURGERY SUPPLEMENT, COMMENTS
Prior Surgery form for C3D 3.12 Adopters Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF2F7B22-5065-707B-E034-0003BA3F9857

Eligibility Complications NCT00968045

- 08/01/18 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Fibrinogen and Bleeding After Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00968045

Treatment - Gynecologic Oncology Group Surgical Status Form - 2918053v1.0 - Gynecologic Oncology Group Surgical Status Form

- 09/01/15 - 1 Formulaire, 7 Groupes Item, 28 Eléments de données, 1 Langue
Groupes Item: HEADER MODULE, SURGICAL INFORMATION, FIRST SURGICAL PROCEDURE, SECOND SURGICAL PROCEDURE, THIRD SURGICAL PROCEDURE, FOURTH SURGICAL PROCEDURE, Comments
Gynecologic Oncology Group Surgical Status Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E5EDF6F-8B38-E23E-E040-BB89AD435A10

Eligibility Rheumatoid Arthritis NCT00650078

- 20/09/21 - 1 Formulaire, 2 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00650078

Eligibility Heart Transplantation NCT00723281

- 07/04/18 - 1 Formulaire, 2 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Comparison of CT Angiography With Conventional Angiography and Intravascular Ultrasound in Heart Transplant Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00723281

Eligibility Early Rheumatoid Arthritis NCT01185301

- 08/12/19 - 1 Formulaire, 2 Groupes Item, 17 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA); ODM derived from: https://clinicaltrials.gov/show/NCT01185301

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial